Robert M. Centor, MD; Jeffrey A. Linder, MD, MPH
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Linder has disclosed the following: Stock options/holdings: Amgen, Biogen, Eli Lilly.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Audio. Annals On Call - Fusobacterium Pharyngitis Debate: Dr. Centor discusses the diagnosis and treatment of pharyngitis in adolescents and young adults with Dr. Jeffrey Linder of Northwestern University.
Other Audio Options: Download MP3
Centor RM, Linder JA. Annals On Call - Fusobacterium Pharyngitis Debate. Ann Intern Med. 2019;171:OC1. doi: https://doi.org/10.7326/A19-0010
Download citation file:
Published: Ann Intern Med. 2019;171(4):OC1.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use